Skip to main content
MedPathMedPath Home
Clinical Trials/CTRI/2022/02/040297
CTRI/2022/02/040297
Completed
Phase 2

Preclinical and clinical evaluation of the effect on oral administration of PARUMA NOI NIVARANA MAATHIRAI & NEERMULLI OORAL KUDINEER along with external therapy PODI THIMIRTHAL in the management of BAALAR ATHITHOOLA ROGAM.

Dr J Mangalavalli0 sites40 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsHealth Condition 1: E65- Localized adiposityHealth Condition 2: E660- Obesity due to excess caloriesHealth Condition 3: E663- Overweight

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Health Condition 1: E65- Localized adiposityHealth Condition 2: E660- Obesity due to excess caloriesHealth Condition 3: E663- Overweight
Sponsor
Dr J Mangalavalli
Enrollment
40
Status
Completed
Last Updated
2 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
July 17, 2023
Last Updated
2 years ago
Study Type
Interventional

Investigators

Sponsor
Dr J Mangalavalli

Eligibility Criteria

Inclusion Criteria

  • •1\.Inappropriate weight for height
  • •2\.Raised BMI
  • •3\.Abdominal adiposity
  • •4\.Increased skin fold thickness
  • •All of these associated with any one of the following :
  • •a.Shortness of breath
  • •b.Dark and thickened skin especially in the skin folds and creases
  • •c.Joint pain
  • •d.Trouble sleeping
  • •5\.Willing for regular follow\-up in OPD

Exclusion Criteria

  • •1\.Children above 12 years
  • •2\.Children below 5 years
  • •3\.Cases due to endocrine reasons
  • •4\.Hypothalamic obesity
  • •5\.Genectic syndromes
  • •6\.Monogenic disorders
  • •7\.Under the use of antiepileptic drugs,corticosteroids,antipsychotics,antidepressants and oestrogen

Outcomes

Primary Outcomes

Not specified

Similar Trials

Not yet recruiting
Phase 2
Preclinical and Clinical evaluation of the effect on oral administration of PARANGI KASAYAM along with external application of VARMAM THERAPHY in the management of INFANTILE HEMIPLEGIA in childreHealth Condition 1: G819- Hemiplegia, unspecified
CTRI/2022/11/046972DR M MUKILA
Completed
Phase 2
Preclinical and clinical evaluation of Siddha classical drug KARUNJEERAKA MATHIRAI (oral administration)along with application of NUNAA TAILAM(external) in the management of VITILIGO in childre
CTRI/2022/01/039863Dr S Surendar
Completed
Phase 2
Preclinical and clinical evaluation of the effect of siddha classical drug MANITHAKKALI ENNAI (oral administration) in the management of VITAMIN -B COMPLEX DEFICIENCYHealth Condition 1: E539- Vitamin B deficiency, unspecified
CTRI/2022/02/039956Dr S Aiswarya40
Completed
Phase 2
Preclinical and clinical evaluation of the effect of Siddha classical drug GANTHAGA NEI(oral administration) along with NATHTHAICHOORI TAILAM(external therapy) in the management of CEREBRAL PALSY.Health Condition 1: G801- Spastic diplegic cerebral palsyHealth Condition 2: G802- Spastic hemiplegic cerebral palsy
CTRI/2022/06/043082Dr P RAJAVATHANA40
Active, not recruiting
Phase 2
Preclinical and clinical evaluation of siddha classical drug MEDATHAARI CHOORANAM (oral administration) and CHITHIRAMOOLA TAILAM (external) in the management of JUVENILE ARTHRITIS.
CTRI/2022/01/039856Dr P Ponsridharani